Why it is time for an update on giant cell arteritis

Clin Exp Ophthalmol. 2021 Mar;49(2):99-101. doi: 10.1111/ceo.13903.

Authors

Clare L Fraser¹, Anthony M Sammel^{2

3}

Affiliations

¹ Save Sight Institute, Faculty of Health and Medicine, The University of Sydney, Sydney, New South Wales, Australia.
² Department of Rheumatology, Prince of Wales Hospital, Randwick, New South Wales, Australia.
³ Prince of Wales Clinical School, University of New South Wales, Randwick, New South Wales, Australia.

PMID: 33665952
DOI: 10.1111/ceo.13903

No abstract available

Publication types

Editorial
Comment

MeSH terms

Giant Cell Arteritis* / diagnosis
Giant Cell Arteritis* / drug therapy
Glucocorticoids / therapeutic use
Humans

Substances

Glucocorticoids